Veradermics, Incorporated ( MANE) - Stock Earnings
MANE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
MANE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -21.8 million USD | — USD |
| 2026Q1 | -27.2 million USD | — USD |
| 2026Q2 | -23.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MANE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.5 million USD | — USD |
| 2024 | -26.5 million USD | — USD |
| 2025 | -70.0 million USD | — USD |
| 2026 Est. | — | — |
MANE
Price: $114.37
52 week price:
Earnings Per Share: -2.49 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.9 billion